Adaptin Bio (APTN) Non Operating Income (2024 - 2026)
Adaptin Bio's (APTN) quarterly Non Operating Income came in at -$4696.0 in Q2 2026, down 141.69% quarter-over-quarter from -$1943.0 in Q1 2026.
Analysis
Adaptin Bio (APTN) Non Operating Income (2024 - 2026) Analysis & Trends
Adaptin Bio has disclosed Non Operating Income across 3 years of filings, most recently posting -$4696.0 for Q2 2026.
- In Q2 2026, Non Operating Income changed N/A year-over-year to -$4696.0; the TTM figure through Jun 2026 stood at -$6639.0 (up 96.9% YoY), while the FY2025 annual figure was $247374.0, up 144.76% from the prior year.
- Non Operating Income came in at -$4696.0 for Q2 2026 at Adaptin Bio, down from -$1943.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $247374.0 in Q1 2025 to a low of -$348756.0 in Q4 2024.
- Average Non Operating Income over 3 years is -$44562.4, with a median of -$39696.0 recorded in 2024.
- Year-over-year, Non Operating Income surged 723.17% in 2025 and plunged 100.79% in 2026.
- Over 3 years, Non Operating Income stood at -$348756.0 in 2024, then surged by 170.93% to $247374.0 in 2025, then slumped by 101.9% to -$4696.0 in 2026.
- Per Business Quant data, the three most recent Non Operating Income figures were -$4696.0 in Q2 2026, -$1943.0 in Q1 2026, and $247374.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.26 Bn | 9.41 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | 27.08 Mn |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn | - |
| 4 | Legend Biotech | 3.67 Bn | 2.71 Bn | 251.50 Mn | - |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn | - |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - | 3.88 Mn |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn | -2.57 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn | -15.04 Mn |
| 9 | Vericel | 1.98 Bn | 1.81 Bn | 56.40 Mn | 1.77 Mn |
| 10 | Adaptin Bio | 56.76 Mn | 56.09 Mn | - | -4,696.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4,696.00 |
| Mar 31, 2026 | -1,943.00 |
| Mar 31, 2025 | 247,374.00 |
| Dec 31, 2024 | -348,756.00 |
| Sep 30, 2024 | -112,802.00 |
| Jun 30, 2024 | -51,418.00 |
| Mar 31, 2024 | -39,696.00 |